Wet AMD 2 Symposium

Related

• 

  Two-Year Results From the Subretinal RGX-314 Gene Therapy Phase 1/2a Study for the Treatment of Neovascular AMD

  Robert L. Avery, MD

  Updates from the Field

  2021

• 

  Episode 8: DAVE Trial: Targeted Retinal Photocoagulation for DME with Dr. David Brown

  Keyvan Koushan, MD, FRCSC

  Member Podcasts

  2018

• 

  Sustained Diabetic Retinopathy Severity Improvement With Intravitreal Aflibercept in DME: Post Hoc Analysis of VISTA and VIVID

  Rishi P. Singh, MD

  Annual Meeting Talks

  2019